No Pharma Money
News & Reports
News March 18, 2019

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

Will PhRMA partner with Lori Loughlin in an attempt to improve its reputation?
 
1. Bonuses for bad behavior

  • High drug prices mean multitudes of millions for CEOs like David Ricks of Eli Lilly and Richard Gonzalez of AbbVie. — (FiercePharma, FiercePharma) 

2. She sold everything — twice

  • A patient living with Type 1 diabetes explained how she sold all of her belongings — twice — to stay alive and afford insulin. — (BBC) 

 
3. Isn’t sepsis frightening enough? 

  • The price of a longtime ICU staple to treat sepsis has spiked in price from $200 to $4,000. Now greedy pharma is suing to stop compounded alternatives that seek to ease hospital budget woes. — (STAT)

 
4. Everyone gets a piece of the pie

  • Pharma, PBMs, and insurers all dine at the table of high drug prices.— (Pew)

 
5. We’re not gonna take it

  • AARP launched a landmark campaign against high drug prices and corporate greed. The nationwide campaign calls on its 37 million members to tell Congress to cut drug prices now. — (Forbes)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.